Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Ondansetron

Ondansetron
In stock
4mg · 8mg
from 45,86 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
55,04 £45,86 £
1,53 £ per tablet

In brief

  • In our pharmacy, you can buy ondansetron without a prescription, with delivery across the United Kingdom in 9–21 days. Discreet and secure packaging is available.
  • Ondansetron is used to prevent and treat nausea and vomiting (including postoperative, chemotherapy- and radiotherapy-induced nausea). It is a selective 5‑HT3 (serotonin) receptor antagonist that blocks serotonin receptors in the gut and the chemoreceptor trigger zone.
  • The usual adult dose is 4 mg orally every 8 hours as needed; for prevention of chemotherapy-induced nausea commonly 8 mg orally or IV given before chemotherapy. Do not exceed 24 mg in 24 hours without medical advice; paediatric and IV regimens differ and should follow age/weight guidance.
  • The forms of administration include oral tablets (including orally disintegrating tablets), oral solution, and injection (IV/IM).
  • The effect begins within about 30 minutes after an oral dose and within 5–10 minutes after IV administration.
  • The duration of action is typically around 6–12 hours (plasma half‑life approximately 3–4 hours), so dosing is commonly every 8 hours when required.
  • Avoid heavy alcohol while taking ondansetron; alcohol can increase dizziness and other side effects and dehydration or electrolyte imbalance may increase risks such as QT prolongation when combined with certain medicines.
  • The most common side effects are headache, constipation, dizziness and fatigue; rare but serious effects include QT prolongation and allergic reactions.
  • Would you like to try ondansetron without a prescription?

Basic ondansetron information

  • INN (international nonproprietary name): Ondansetron (as ondansetron hydrochloride)
  • Brand names available in the United Kingdom: Zofran; generic ondansetron
  • ATC code: A04AA01
  • Forms and dosages: Tablets 4 mg and 8 mg; orodispersible tablets 4 mg and 8 mg; oral solution 4 mg/5 mL; injection 2 mg/mL
  • Manufacturers in the United Kingdom: Novartis (Zofran); generic ondansetron from several manufacturers
  • Registration status in the United Kingdom: Licensed by the MHRA; prescription-only medicine (POM)
  • OTC / Rx classification: Prescription-only medicine (POM)

Critical warnings, precautions and patient protection for UK users

Ondansetron can prolong the QT interval and, in rare cases, cause serious cardiac arrhythmias.

There is a risk of serotonin syndrome when ondansetron is combined with SSRIs, SNRIs, MAOIs or triptans.

MHRA guidance emphasises caution in pregnancy; pregnant patients must discuss risks and benefits with their obstetrician or GP and must not self-prescribe.

Elderly patients and people with liver disease may need dose adjustment, ECG monitoring and electrolyte checks before starting ondansetron.

  • Absolute contraindications: Known hypersensitivity to ondansetron; concomitant use with apomorphine.
  • Caution flags: Pre-existing QT prolongation, hypokalaemia, hypomagnesaemia, severe hepatic impairment, concurrent QT‑prolonging drugs.
  • Monitoring steps: Baseline ECG if cardiac history; check potassium and magnesium; review full medication list for serotonergic or QT‑prolonging drugs.

Q&A — Can I drive after taking it in the UK?

If ondansetron causes dizziness, fainting or drowsiness, do not drive or operate heavy machinery.

Contact your GP, pharmacist or the DVLA for guidance if you experience seizures, syncope or persistent drowsiness.

INN, UK brand names and legal classification

INN and brands

Ondansetron is the International Nonproprietary Name (INN) for the drug commonly used to prevent nausea and vomiting.

Common UK brands include Zofran and generic ondansetron in film‑coated and orodispersible tablet forms.

  • Common strengths: 4 mg, 8 mg.
  • Common forms: Tablet, orodispersible tablet (ODT), intravenous solution.

Legal classification (POM, P, GSL)

Ondansetron is classified as a prescription‑only medicine (POM) in the UK and must be supplied on an NHS or private prescription.

NHS electronic prescriptions and private e‑prescriptions are accepted by community pharmacies and hospital supply chains.

INN:
Ondansetron.
Common brand:
Zofran and generic ondansetron film‑coated or orodispersible tablets.
POM status:
Prescription‑only medicine in the UK.

Standard regimens and NHS guidance

Standard adult dosing

Typical adult oral doses are 4 mg or 8 mg depending on indication.

Four milligram doses are frequently used for acute or post‑operative nausea and vomiting.

Eight milligram doses are commonly used in chemotherapy antiemesis and scheduled dosing may be required during treatment courses.

Intravenous equivalents are used in hospital for severe or immediate control.

Adjustments for comorbidities

Dosing should be reduced or carefully monitored in hepatic impairment due to slower metabolism and increased exposure.

Correct hypokalaemia and hypomagnesaemia before administration and review concomitant QT‑prolonging drugs.

Q&A — What if I miss a dose?

For a single acute dose, take it as soon as you remember if still needed.

For scheduled courses, take the missed dose unless it is nearly time for the next dose; do not double up.

  • Starting checks: ECG where indicated, electrolytes, full drug review.
  • Titration notes: Use lowest effective dose and review necessity regularly for repeat prescriptions.

Food, drink and drug interactions

Food and beverages

There are no major food interactions with ondansetron, but alcohol can increase dizziness and worsen nausea.

Avoid excessive alcohol after post‑operative use while recovering.

Key drug conflicts

Important interactions include other QT‑prolonging drugs such as some antiarrhythmics, certain antipsychotics and some macrolide antibiotics.

Concomitant serotonergic agents (SSRIs, SNRIs, MAOIs, triptans) raise the risk of serotonin syndrome.

Use with apomorphine is contraindicated.

Report suspected side effects to the MHRA Yellow Card scheme to help safety monitoring.

Interacting drug category Clinical risk Management
QT‑prolonging drugs (e.g. certain antipsychotics, amiodarone) Increased risk of torsades de pointes Avoid combination or monitor ECG and electrolytes
Serotonergic agents (SSRIs, SNRIs, triptans) Serotonin syndrome Review necessity, monitor for agitation, hyperreflexia, fever
Apomorphine Severe hypotension and loss of consciousness Contraindicated — do not co‑administer

Legal status and availability in the UK

In our online pharmacy, ondansetron is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

How ondansetron works (plain English and clinical terms)

Simplified explanation

Ondansetron blocks 5‑HT3 serotonin receptors in the gut and brainstem, reducing the nausea and vomiting signal to the brain.

This action is why ondansetron is effective for chemotherapy, radiotherapy and post‑operative nausea.

Clinical pharmacology terms

Onset of effect is typically within 30–60 minutes after oral dosing.

Plasma half‑life in adults is around 3–6 hours and the drug is predominantly metabolised by hepatic CYP enzymes.

5‑HT3 antagonist
Blocks serotonin receptors involved in vomiting reflexes.
Chemoreceptor trigger zone
Brain area where ondansetron reduces emetic signalling.
QT interval
Cardiac repolarisation measure; can be prolonged by ondansetron in high risk patients.
Metabolism
Primarily hepatic via CYP pathways with implications for liver impairment and interactions.

Approved uses and NHS practice

MHRA‑approved indications

Ondansetron is approved for prevention and treatment of chemotherapy‑, radiotherapy‑ and post‑operative nausea and vomiting.

Intravenous ondansetron is commonly used in hospitals for severe acute cases.

Off‑label and cautious uses

Clinicians sometimes use ondansetron off‑label for refractory nausea from other causes when standard therapies fail.

Pregnancy use requires careful benefit/risk assessment and often obstetrician input before prescribing.

  • Approved: Chemotherapy, radiotherapy and post‑operative nausea and vomiting.
  • Off‑label: Refractory nausea from other causes — use with caution in pregnancy.

NHS prescribing alternatives and decision checklist

Alternatives and comparison

Alternative antiemetics on the NHS include cyclizine, prochlorperazine, metoclopramide and domperidone, each with different side‑effect profiles.

Choice depends on cause of nausea, patient comorbidities and cardiac history.

Drug Typical indication Pros Cons Cardiac risk
Cyclizine Motion sickness, severe nausea Effective for vestibular causes Anticholinergic side effects Low
Prochlorperazine Acute severe nausea Strong antiemetic effect Extrapyramidal side effects Moderate
Domperidone Gastroparesis, nausea Prokinetic effect QT prolongation concerns Higher — monitor ECG

Pros and cons checklist

  • Confirm indication and likely cause of nausea.
  • Review cardiac history and concomitant medications.
  • Check pregnancy status and consult obstetrics where required.
  • Decide on route of administration (oral vs IV) and patient preference.

Common questions (patient FAQs)

  • Is ondansetron safe in pregnancy? — Discuss with your obstetrician or GP; MHRA advises benefit versus risk assessment and specialist input where needed.
  • How quickly does it work? — Oral ondansetron often starts working within 30–60 minutes.
  • Can children take it? — Paediatric dosing exists and must be prescribed by a paediatrician or GP; formulations include ODT and liquid in some settings.

For urgent concerns contact NHS 111, your GP or speak to a pharmacist for immediate advice.

MHRA approval, NICE guidance and prescribing framework

MHRA processes and safety monitoring

The MHRA licences medicines, issues safety alerts and operates the Yellow Card scheme for adverse event reporting.

Report any suspected side effects via the Yellow Card to contribute to post‑marketing surveillance.

NHS prescribing framework

Hospital formularies guide IV ondansetron use, while primary care GPs prescribe oral courses for community treatment.

Specialist oncology teams manage antiemesis protocols for chemotherapy patients.

  • Include indication, dose, route and duration on prescriptions.
  • Document ECG history, pregnancy status and concomitant meds when relevant.

UK household and clinical storage advice

Household storage (cold/damp climate)

Store ondansetron at room temperature and protect it from moisture and light.

Keep the medicine in its original packaging and out of reach of children.

Dispose of unused tablets via pharmacy take‑back schemes.

Clinical handling

Hospital IV preparations must be prepared aseptically and labelled according to pharmacy protocols.

Check expiry after reconstitution and follow local nursing guidelines for administration.

  • For ODTs: keep blister intact until use and place on the tongue to dissolve.
  • For travel: carry a copy of your prescription and store below 25°C where possible.

Pharmacist counselling style and NHS patient safety advice

Counselling checklist for UK pharmacists

  • Confirm the indication and check for allergies.
  • Ask about pregnancy, breastfeeding and childbearing potential.
  • Review the full medication list, especially QT‑prolonging and serotonergic drugs.
  • Explain dosing, timing and possible side effects such as headache and constipation.
  • Advise on driving and when to seek urgent care: chest pain, palpitations, fainting, seizures or severe allergic reaction.

Practical patient safety measures

Provide a written action plan for post‑op or chemotherapy antiemesis and suggest a medication card listing allergies and ECG‑relevant history.

Encourage patients to report adverse effects to the MHRA Yellow Card scheme and to follow up with their GP.

Delivery across the United Kingdom

City Region Delivery time
London England 9–21 days
Manchester England 9–21 days
Birmingham England 9–21 days
Glasgow Scotland 9–21 days
Edinburgh Scotland 9–21 days
Leeds England 9–21 days
Liverpool England 9–21 days
Bristol England 9–21 days
Newcastle England 9–21 days
Aberdeen Scotland 9–21 days
Plymouth England 9–21 days
Swansea Wales 9–21 days
Inverness Scotland 9–21 days

Related products